Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.43 |
| ▸ | CCR5 | P51681 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11131062 | 0.81 | CCR1 (0.70) | CCR1CCR5KDM4EGMNNLMNA | |
| SCHEMBL15593262 | 0.78 | CCR1 (0.38) | CCR1CCR5RAB9ACCR8 | |
| SCHEMBL18963352 | 0.77 | CYP2A6 (0.48) | RAB9AKDM4ELMNACYP3A4MAPT | |
| SCHEMBL5183354 | 0.77 | KDM4E (0.33) | KDM4ELMNATP53HSP90AA1CYP3A4 | |
| SCHEMBL3215551 | 0.75 | METAP2 (0.59) | RAB9AKDM4ELMNATP53HSP90AA1 | |
| SCHEMBL16535454 | 0.75 | BACE1 (0.59) | CCR1CCR5RAB9AKDM4EGMNN | |
| SCHEMBL19044615 | 0.75 | AR (0.44) | CCR1CCR5RAB9AKDM4EGMNN | |
| SCHEMBL19044445 | 0.74 | CYP2A6 (0.41) | CCR1CCR5RAB9AKDM4EGMNN | |
| SCHEMBL19044504 | 0.69 | CCR1 (0.34) | CCR1CCR5RAB9ACCR8 | |
| SCHEMBL20928077 | 0.66 | KMT2A (0.44) | CCR1CCR5RAB9AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159334-A1 | NITROGEN-CONTAINING CARBON MATERIAL AND METHOD FOR PRODUCING SAME | NICHIA CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| US-20210062251-A1 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | Roche Sequencing Solutions, Inc. | 2021-03-04 | — | — | US | disclosed |
| US-20210028367-A1 | ANTHRACENE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
| US-20120032158-A1 | Charge transport compositions and electronic devices made with such compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-09 | — | — | US | disclosed |
| US-8071975-B2 | Electronic devices made with electron transport and/or anti-quenching layers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-12-06 | — | — | US | disclosed |
| US-20090121617-A1 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | LG CHEM, LTD. (KR) | 2009-05-14 | — | — | US | disclosed |
| US-20070267968-A1 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | LECLOUX DANIEL D | 2007-11-22 | — | — | US | disclosed |
| US-7265378-B2 | Electronic devices made with electron transport and/or anti-quenching layers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7119204-B2 | Charge transport compositions and electronic devices made with such compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-10-10 | — | — | US | disclosed |
| US-6962995-B2 | Charge transport compositions and electronic devices made with such compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-11-08 | — | — | US | disclosed |
| US-20050236980-A1 | Charge transport compositions and electronic devices made with such compounds | LG CHEM, LTD. (KR) | 2005-10-27 | — | — | US | disclosed |
| EP-1519935-A2 | CHARGE TRANSPORT COMPOSITIONS COMPRISING FLUORINATED PHENANTHROLINE DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-04-06 | — | — | EP | disclosed |
| EP-1520452-A2 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-04-06 | — | — | EP | disclosed |
| US-20040068115-A1 | Charge transport compositions and electronic devices made with such compositions | LG CHEM, LTD. (KR) | 2004-04-08 | — | — | US | disclosed |
| US-20040066135-A1 | Electronic devices made with electron transport and/or anti-quenching layers | LG CHEM, LTD. (KR) | 2004-04-08 | — | — | US | disclosed |
| WO-2004006352-A2 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004005288-A2 | CHARGE TRANSPORT COMPOSITIONS COMPRISING FLUORINATED PHENANTHROLINE DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210028367-A1 | ANTHRACENE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, CRY1, AHR | CCR1 2497/4885CCR5 4083/4885RAB9A 3144/4885 |
| US-20050236980-A1 | Charge transport compositions and electronic devices made with such compounds | SLC26A3, SLC18A3, SLC6A19 | CCR1 1129/4885CCR5 2087/4885RAB9A 1177/4885 |
| US-20210062251-A1 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | POLN, POLB, POLRMT | CCR1 2386/4885CCR5 1861/4885RAB9A 3630/4885 |
| US-20230159334-A1 | NITROGEN-CONTAINING CARBON MATERIAL AND METHOD FOR PRODUCING SAME | NPM1, NCLN, C5 | CCR1 607/4885CCR5 2230/4885RAB9A 2825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.